Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: Paul Barr who wrote (4104)	4/17/1998 11:43:00 AM
From: Steve Fancy	Read Replies (2) \| Respond to of 6136

Mr Barr, An excerpt from the conference call below. FWIW, as of the conference call, Roche had not reported actual sales yet. I could list a few others, but don't need to prove anything to you, and will not try. Call my statements dump, stupid, whatever...but I didn't make the stuff up. I'm still very long the company, but have some concerns that I will watch closely. As far as SI, there are some very valuable threads here, you just need to know where to look. I guess when you only come around once in a while, a lot of valuable information may go over your head...there's a lot of good information here if you look. Question: Do you expect quarter over quarter increase in viracept sales? Which countries is it marketed in now? Answer from Mr Snyder: with more countries coming on, we would expect increase in sales to roche compared to Q3. Too early to project if of same magnitude as Q2 to Q3. *Approved in 26 countries, probably available in half.* If all you can be is nasty regarding issues that maybe you don't understand, I'd suggest you take your business elsewhere. sf